Purchase Order 75N98024P01778
- Not listed
- This is a firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. The $34,505.63 contract is for the provision of Illumina's sequencing and array-based genomic analysis products and services, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, consumables, sample prep kits, and bioinformatics capabilities. This contract supports the agency's genomic sequencing and...
- This is a $11,044.52 firm fixed price purchase order awarded by the National Eye Institute, a component of the National Institutes of Health, to Illumina, Inc. The contract is for the provision of Illumina's genetic sequencing and analysis instruments, reagents, and associated support services. This includes NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with related consumables and bioinformatics products. The contract has an ultimate completion date of June 24, 2025 and does not...
- This is a firm fixed-price purchase order awarded by the National Eye Institute (NEI), a civilian agency within the Department of Health and Human Services, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $76,786.00, is for the procurement of NextSeq2000 reagents to support the agency's next-generation sequencing (NGS) work. Illumina is a for-profit organization and manufacturer of goods, and the contract does not utilize...
- This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and analytical products. The $24,728.01 contract is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, and...
- This is a $141,629.53 firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and reagents. The order is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This award is...
- The Department of Health and Human Services' National Institutes of Health National Eye Institute awarded a $142,810.50 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis instruments and reagents. The award is for the provision of an analytical laboratory instrument, with a completion date of August 24, 2024. Illumina has been a prime contractor on numerous federal contracts across agencies like the NIH, CDC, USDA, and VA, primarily...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $64,858.50 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits,...
- This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The contract, valued at $100,213.37, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $147,003.32 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...
- This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
This is a $29,284.10 firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Eye Institute to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis products. The contract is for the delivery of unspecified drugs and bio products, with a completion date of May 13, 2025. There is no set-aside designation noted for this award. Based on Illumina's history of providing sequencing systems, reagents, and services to support genomic research and diagnostics across federal agencies, this contract is likely to involve the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms, along with accompanying consumables and support services, to support the National Eye Institute's research and clinical programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.3k | 5/14/24 |